• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TK Modeler 版本 1.0,一个基于 Microsoft® Excel®的建模软件,用于预测毒代动力学研究中药物的日时血/血浆浓度。

TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.

机构信息

Toxicology & Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA.

出版信息

Regul Toxicol Pharmacol. 2012 Jul;63(2):333-43. doi: 10.1016/j.yrtph.2012.04.002. Epub 2012 Apr 13.

DOI:10.1016/j.yrtph.2012.04.002
PMID:22504463
Abstract

TK Modeler 1.0 is a Microsoft® Excel®-based pharmacokinetic (PK) modeling program created to aid in the design of toxicokinetic (TK) studies. TK Modeler 1.0 predicts the diurnal blood/plasma concentrations of a test material after single, multiple bolus or dietary dosing using known PK information. Fluctuations in blood/plasma concentrations based on test material kinetics are calculated using one- or two-compartment PK model equations and the principle of superposition. This information can be utilized for the determination of appropriate dosing regimens based on reaching a specific desired C(max), maintaining steady-state blood/plasma concentrations, or other exposure target. This program can also aid in the selection of sampling times for accurate calculation of AUC(24h) (diurnal area under the blood concentration time curve) using sparse-sampling methodologies (one, two or three samples). This paper describes the construction, use and validation of TK Modeler. TK Modeler accurately predicted blood/plasma concentrations of test materials and provided optimal sampling times for the calculation of AUC(24h) with improved accuracy using sparse-sampling methods. TK Modeler is therefore a validated, unique and simple modeling program that can aid in the design of toxicokinetic studies.

摘要

TK Modeler 1.0 是一个基于 Microsoft Excel 的药代动力学(PK)建模程序,旨在帮助设计毒代动力学(TK)研究。TK Modeler 1.0 使用已知的 PK 信息预测单次、多次推注或饮食给药后测试物质的昼夜血液/血浆浓度。基于测试物质动力学的血液/血浆浓度波动使用单或双室 PK 模型方程和叠加原理进行计算。此信息可用于确定适当的给药方案,以达到特定的预期 C(max)、维持稳态血液/血浆浓度或其他暴露目标。该程序还可以帮助选择采样时间,以使用稀疏采样方法(一个、两个或三个样本)准确计算 AUC(24h)(昼夜血液浓度时间曲线下面积)。本文描述了 TK Modeler 的构建、使用和验证。TK Modeler 准确预测了测试物质的血液/血浆浓度,并提供了最佳的采样时间,使用稀疏采样方法可提高 AUC(24h)计算的准确性。因此,TK Modeler 是一个经过验证的、独特的、简单的建模程序,可以帮助设计毒代动力学研究。

相似文献

1
TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.TK Modeler 版本 1.0,一个基于 Microsoft® Excel®的建模软件,用于预测毒代动力学研究中药物的日时血/血浆浓度。
Regul Toxicol Pharmacol. 2012 Jul;63(2):333-43. doi: 10.1016/j.yrtph.2012.04.002. Epub 2012 Apr 13.
2
Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use.评估监管毒理学测试中农用化学品的日间全身剂量--一种无需额外动物使用的综合方法。
Regul Toxicol Pharmacol. 2012 Jul;63(2):321-32. doi: 10.1016/j.yrtph.2012.03.004. Epub 2012 Mar 14.
3
The use of C(av) rather than AUC in safety assessment.在安全性评估中使用 C(av)而非 AUC。
Regul Toxicol Pharmacol. 2010 Jun;57(1):70-3. doi: 10.1016/j.yrtph.2010.01.001. Epub 2010 Jan 13.
4
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.IVIVE 和 PBPK 模型在临床药代动力学前瞻性预测中的应用:药物发现阶段的策略和方法,附四个案例研究。
Biopharm Drug Dispos. 2012 Mar;33(2):85-98. doi: 10.1002/bdd.1769. Epub 2012 Jan 24.
5
Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.一种易于使用、准确且灵活的个体化贝叶斯有限采样方法,用于肝移植后环孢素监测,无需固定时间点。
Aliment Pharmacol Ther. 2005 Mar 1;21(5):549-57. doi: 10.1111/j.1365-2036.2005.02364.x.
6
The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteers.稀疏数据采样对群体药代动力学的影响:一项健康志愿者中吗啡药代动力学研究的事后分析。
Clin Ther. 2012 Mar;34(3):668-76. doi: 10.1016/j.clinthera.2012.01.023. Epub 2012 Feb 28.
7
Non-compartmental analysis.非房室分析。
Methods Mol Biol. 2012;929:377-89. doi: 10.1007/978-1-62703-050-2_16.
8
Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.健康男性志愿者中每日 1 次给予盐酸普拉克索控释片的药代动力学:3 项研究。
Clin Ther. 2009 Nov;31(11):2698-711. doi: 10.1016/j.clinthera.2009.10.018.
9
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.低剂量奈达铂在非小细胞肺癌患者中的药代动力学及AUC预测的验证
Cancer Chemother Pharmacol. 2007 Apr;59(5):575-80. doi: 10.1007/s00280-006-0298-2. Epub 2006 Aug 16.
10
Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.万古霉素剂量:治疗浓度时间评估和药代动力学模型软件预测准确性。
Ann Pharmacother. 2011 Jun;45(6):757-63. doi: 10.1345/aph.1P634. Epub 2011 Jun 7.

引用本文的文献

1
Upholding or Breaking the Law of Superposition in Pharmacokinetics.坚守或打破药代动力学中的叠加定律
Biomedicines. 2024 Aug 13;12(8):1843. doi: 10.3390/biomedicines12081843.
2
Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.预测未来:化学工业应用21世纪毒性测试的机遇与挑战。
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):214-23.
3
Life-stage-, sex-, and dose-dependent dietary toxicokinetics and relationship to toxicity of 2,4-dichlorophenoxyacetic acid (2,4-D) in rats: implications for toxicity test dose selection, design, and interpretation.
在大鼠中,基于生命阶段、性别和剂量的膳食毒代动力学及其与 2,4-二氯苯氧乙酸(2,4-D)毒性的关系:对毒性试验剂量选择、设计和解释的影响。
Toxicol Sci. 2013 Dec;136(2):294-307. doi: 10.1093/toxsci/kft212. Epub 2013 Oct 8.